Xiao Bing Li
Corporate Officer/Principal chez CLOVER BIOPHARMACEUTICALS, LTD.
Profil
Xiao Bing Li is currently the Executive Vice President at Clover Biopharmaceuticals Ltd.
Prior to this, he held positions as Senior Director at Ironwood Pharmaceuticals, Director at Janssen Pharmaceuticals, Director at Alkermes Plc, and Senior Director at SAGE Therapeutics.
He also served as Vice President-Program Management at Voyager Therapeutics.
Dr. Li holds a doctorate from Princeton University, an MBA from Colorado State University, and an undergraduate degree from Nankai University.
Postes actifs de Xiao Bing Li
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Corporate Officer/Principal | 27/07/2020 |
Anciens postes connus de Xiao Bing Li
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Director/Board Member | 01/05/2018 |
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 01/03/2016 |
| ALKERMES PLC | Director/Board Member | 01/07/2014 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Director/Board Member | 01/09/2010 |
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Xiao Bing Li
| Colorado State University | Masters Business Admin |
| Princeton University | Doctorate Degree |
| Nankai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
